Key result
Urinary NT-proBNP identifies pediatric septic shock with moderate accuracy, performing comparably to serum testing.
Why the study?
The 2024 Phoenix Sepsis Score may not fully capture subclinical cardiovascular stress in pediatric sepsis.
Does urinary NT-proBNP accurately discriminate septic shock from sepsis in pediatric patients compared to serum NT-proBNP?
Cross-Sectional (n=52)
No
Does urinary NT-proBNP accurately discriminate septic shock from sepsis in pediatric patients compared to serum NT-proBNP?
Urinary NT-proBNP offers a noninvasive, highly specific adjunctive biomarker for identifying cardiovascular stress and septic shock in pediatric patients, performing comparably to serum NT-proBNP.
Answers are grounded in this paper and cite their sources.
Urinary NT-proBNP may support noninvasive septic shock identification in children; hypothesis-generating and requires prospective validation before adoption.
Background The 2024 Phoenix Sepsis Score (PSS) may not fully capture subclinical cardiovascular stress in pediatric sepsis. N-terminal pro–B-type natriuretic peptide (NT-proBNP), released under haemodynamic strain, is measurable in urine and serum and has been associated with cardiovascular dysfunction. This study aimed to compare urinary and serum NT-proBNP levels in pediatric sepsis and septic shock, evaluate their ability to differentiate these conditions, and examine their correlations with PSS. Methods Participants aged 1 month–18 years with sepsis or septic shock according to PSS were included in this prospective cross-sectional analytical study at a tertiary hospital in Bandung, Indonesia. Urinary and serum NT-proBNP concentrations were measured within 48 h of diagnosis. Patients with preexisting heart, kidney, or urological problems were excluded. Main analyses included Mann-Whitney U, ROC curves, and Spearman correlations. To evaluate statistical stability, 1,000 bias-corrected and accelerated (BCa) bootstrap iterations, fragility index (FI) analysis, and time-adjusted sensitivity analyses were added. Results Final analyses comprised 52 children (26 sepsis, 26 septic shock). Median urinary NT-proBNP levels were higher in septic shock than in sepsis (8,065 vs. 210 pg/mL; p = 0.003), as were serum NT-proBNP levels (1,655 vs. 200 pg/mL; p = 0.005). Urinary NT-proBNP had an AUC of 0.743 (95% BCa CI 0.584–0.867) for septic shock (cut-off > 9,550 pg/mL, specificity 100%, sensitivity 42.3%, FI = 4), whereas serum NT-proBNP showed an AUC of 0.726 (95% BCa CI 0.573–0.852; cut-off > 1,640 pg/mL, specificity 92.3%, sensitivity 50.0%, FI = 3). Sensitivity analyses confirmed performance stability when restricting collection to ≤ 6 h. Urinary NT-proBNP correlated weakly with PSS ( r = 0.261; p = 0.031), while serum NT-proBNP did not ( r = 0.221; p = 0.058). Conclusions Urinary NT-proBNP demonstrated moderate discriminatory ability and high specificity for pediatric septic shock, comparable to serum NT-proBNP, although its correlation with PSS was modest. It may have potential value as an adjunctive rule-in biomarker for cardiovascular stress in pediatric sepsis, but not as a screening tool or replacement for clinical assessment. Further studies are needed to determine its broader clinical utility in pediatric sepsis.
No takes yet. Share an insight, caveat, or question.
Fauzi et al. (2026) conducted a cross-sectional in Pediatric sepsis and septic shock (n=52). Urinary NT-proBNP vs. Serum NT-proBNP was evaluated on Discriminative ability for septic shock (AUC 0.743, 95% CI 0.584-0.867, p=0.001). Urinary NT-proBNP demonstrated moderate discriminative ability for identifying pediatric septic shock with an AUC of 0.743, performing comparably to serum NT-proBNP.
Synapse has enriched 10 related papers. Consider them for comparative context: